China Pharma Holdings Current Ratio 2010-2023 | CPHI
China Pharma Holdings current ratio from 2010 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
China Pharma Holdings Current Ratio Historical Data |
Date |
Current Assets |
Current Liabilities |
Current Ratio |
2023-09-30 |
$0.01B |
$0.01B |
0.82 |
2023-06-30 |
$0.01B |
$0.01B |
0.52 |
2023-03-31 |
$0.01B |
$0.01B |
0.51 |
2022-12-31 |
$0.01B |
$0.01B |
0.47 |
2022-09-30 |
$0.01B |
$0.01B |
0.44 |
2022-06-30 |
$0.01B |
$0.01B |
0.75 |
2022-03-31 |
$0.01B |
$0.01B |
0.83 |
2021-12-31 |
$0.01B |
$0.01B |
0.87 |
2021-09-30 |
$0.00B |
$0.01B |
0.40 |
2021-06-30 |
$0.01B |
$0.01B |
0.43 |
2021-03-31 |
$0.01B |
$0.01B |
0.44 |
2020-12-31 |
$0.01B |
$0.01B |
0.47 |
2020-09-30 |
$0.01B |
$0.01B |
0.44 |
2020-06-30 |
$0.01B |
$0.01B |
0.64 |
2020-03-31 |
$0.01B |
$0.01B |
0.57 |
2019-12-31 |
$0.01B |
$0.01B |
0.56 |
2019-09-30 |
$0.01B |
$0.01B |
0.65 |
2019-06-30 |
$0.01B |
$0.01B |
0.86 |
2019-03-31 |
$0.01B |
$0.01B |
0.89 |
2018-12-31 |
$0.01B |
$0.01B |
0.87 |
2018-09-30 |
$0.01B |
$0.01B |
0.99 |
2018-06-30 |
$0.01B |
$0.01B |
1.35 |
2018-03-31 |
$0.01B |
$0.01B |
1.40 |
2017-12-31 |
$0.01B |
$0.01B |
1.33 |
2017-09-30 |
$0.02B |
$0.01B |
1.44 |
2017-06-30 |
$0.02B |
$0.01B |
1.64 |
2017-03-31 |
$0.02B |
$0.01B |
1.66 |
2016-12-31 |
$0.02B |
$0.01B |
1.69 |
2016-09-30 |
$0.02B |
$0.01B |
1.62 |
2016-06-30 |
$0.02B |
$0.01B |
1.69 |
2016-03-31 |
$0.03B |
$0.01B |
1.79 |
2015-12-31 |
$0.02B |
$0.01B |
1.90 |
2015-09-30 |
$0.04B |
$0.02B |
2.24 |
2015-06-30 |
$0.04B |
$0.01B |
3.07 |
2015-03-31 |
$0.04B |
$0.02B |
2.79 |
2014-12-31 |
$0.04B |
$0.01B |
2.96 |
2014-09-30 |
$0.06B |
$0.01B |
4.46 |
2014-06-30 |
$0.07B |
$0.01B |
5.81 |
2014-03-31 |
$0.08B |
$0.01B |
6.64 |
2013-12-31 |
$0.08B |
$0.01B |
6.99 |
2013-09-30 |
$0.10B |
$0.01B |
7.59 |
2013-06-30 |
$0.10B |
$0.02B |
6.97 |
2013-03-31 |
$0.11B |
$0.01B |
8.57 |
2012-12-31 |
$0.11B |
$0.02B |
7.69 |
2012-09-30 |
$0.12B |
$0.02B |
7.18 |
2012-06-30 |
$0.12B |
$0.02B |
7.13 |
2012-03-31 |
$0.12B |
$0.02B |
6.78 |
2011-12-31 |
$0.11B |
$0.01B |
8.03 |
2011-09-30 |
$0.11B |
$0.01B |
8.04 |
2011-06-30 |
$0.10B |
$0.01B |
8.19 |
2011-03-31 |
$0.10B |
$0.01B |
7.62 |
2010-12-31 |
$0.09B |
$0.01B |
7.18 |
2010-09-30 |
$0.09B |
$0.01B |
7.73 |
2010-06-30 |
$0.08B |
$0.01B |
6.47 |
2010-03-31 |
$0.08B |
$0.01B |
7.06 |
2009-12-31 |
$0.07B |
$0.01B |
6.79 |
2009-09-30 |
$0.07B |
$0.01B |
6.93 |
2009-06-30 |
$0.06B |
$0.01B |
8.08 |
2009-03-31 |
$0.06B |
$0.01B |
9.32 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$0.003B |
$0.008B |
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
|